Table 1.
Standard Protocol Items: Recommendations for Interventional Trials diagram
Month –0* | Month 0 | Month 1 | Month 2 | Month 3 | Month 4 | Month 6 | Month 9 | Month 15 | ||
---|---|---|---|---|---|---|---|---|---|---|
Enrollment | Patient screening | √ | ||||||||
Patient informed consent | √ | |||||||||
Patient randomization | √ | |||||||||
Intervention | hUC-MSC (arm A) | √ | √ | √ | √ | |||||
Normal saline (arm B) | √ | √ | √ | √ | ||||||
Primary endpoint | √ | √ | √ | √ | √ | √ | √ | √ | ||
Assessment | Secondary endpoints | √ | √ | √ | √ | √ | √ | √ | √ | |
Safety indicators | √ | √ | √ | √ | √ | √ | √ | √ | ||
Other recordings | √ | √ | √ | √ | √ | √ | √ | √ |
*The screening visit. hUC-MSC: Human umbilical cord mesenchymal stem cell.